Retatrutide Research Peptide
Retatrutide is an investigational single peptide that activates the GIP, GLP-1 and glucagon receptors, studied as the best-known unimolecular triple agonist.
10 listed Retatrutide presentations
Each presentation is a separate specification with its own product code. Open one to add it to your inquiry cart or to ask for a quote on WhatsApp. Pricing, availability and lot documents are confirmed for each order.
| Presentation | Per vial | Per box | Product code |
|---|---|---|---|
| Retatrutide 5 mg → | 5 mg | 10 vials | RT5 |
| Retatrutide 10 mg → | 10 mg | 10 vials | RT10 |
| Retatrutide 15 mg → | 15 mg | 10 vials | RT15 |
| Retatrutide 20 mg → | 20 mg | 10 vials | RT20 |
| Retatrutide 30 mg → | 30 mg | 10 vials | RT30 |
| Retatrutide 40 mg → | 40 mg | 10 vials | RT40 |
| Retatrutide 50 mg → | 50 mg | 10 vials | RT50 |
| Retatrutide 60 mg → | 60 mg | 10 vials | RT60 |
| Retatrutide 80 mg → | 80 mg | 10 vials | RT80 |
| Retatrutide 100 mg → | 100 mg | 10 vials | RT100 |
Amounts are per vial. mg, IU and mL describe different quantities and are not interchangeable. For laboratory research use only.
About Retatrutide
Retatrutide is a single synthetic peptide engineered to activate three receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor and the glucagon receptor. Like other long-acting incretin analogues, it carries a fatty-acid moiety that supports albumin binding and an extended half-life.
It remains an investigational compound. In the research literature it is the best-known example of a unimolecular triple agonist, extending the dual-agonist approach of tirzepatide by adding glucagon receptor activity.
Research context
Glucagon receptor signaling influences hepatic glucose output, lipid handling and energy expenditure. Retatrutide is therefore used to study how adding glucagon receptor activity changes the profile of a GIP/GLP-1 agonist, through potency comparisons across the three receptors, signaling assays and preclinical models of energy balance and hepatic lipid metabolism.
What to confirm for Retatrutide
Check these points with our team before you order:
- The strength per vial; each fill is a separate presentation with its own product code.
- Identity documentation for the specific lot. Reference data for investigational peptides are more limited than for established analogues.
- The number of boxes you need and the US delivery destination.
- Which lot documents you require before ordering, such as an identity or purity report.
Retatrutide: frequently asked questions
How is retatrutide different from tirzepatide?
Tirzepatide activates the GIP and GLP-1 receptors. Retatrutide adds glucagon receptor agonism to those two, making it a triple agonist. The two are compared to isolate the contribution of glucagon receptor signaling.
How does retatrutide relate to mazdutide and survodutide?
Mazdutide and survodutide combine GLP-1 and glucagon receptor activity without GIP. Retatrutide covers all three receptors, so the three peptides are often grouped together in research on glucagon receptor co-agonism.
Which Retatrutide presentations are listed?
10 presentations are listed: 5 mg (RT5), 10 mg (RT10), 15 mg (RT15), 20 mg (RT20), 30 mg (RT30), 40 mg (RT40), 50 mg (RT50), 60 mg (RT60), 80 mg (RT80), 100 mg (RT100). Each is packed 10 vials per box, and every presentation has its own specification page and product code.
How do I request a quote for Retatrutide?
Open the presentation you need and use Ask price to message PureForm Biosciences on WhatsApp, or add several materials to the inquiry cart and send them together. Pricing, current availability and lot documents are confirmed in that conversation.
Related research materials
- Tirzepatide →Dual GIP and GLP-1 receptor agonist peptide for incretin research.
- Semaglutide →Long-acting, fatty-acid-modified GLP-1 receptor agonist peptide.
- Survodutide →Investigational dual agonist of the glucagon and GLP-1 receptors.
- Mazdutide →Oxyntomodulin-based dual agonist of the GLP-1 and glucagon receptors.
- Cagrilintide →Long-acting acylated analogue of the pancreatic hormone amylin.
Research Use Only. Retatrutide is supplied strictly for laboratory research. It is not a drug, supplement or medical product and is not for human or veterinary consumption.